The key aspect influencing the company’s performance from a long-term perspective is the production and marketing of pharmaceutical substances belonging into the category of generic pharmaceuticals, i.e. active ingredients whose patent protection has expired. The production of these pharmaceuticals contributes 95% to our total annual revenue.
As of this moment, our customer portfolio consists of over 120 customers from more than 40 countries from all over the world.
FARMAK, a.s. is a predominantly export-oriented company with more than 90% of its revenue coming from exports.
Our most valuable territories are Europe, the United States of America, and several Asian countries.
Our marketing activities are reinforced by our regular active participation in mostly international exhibitions, e.g. CPhI Worldwide and DCAT in New York.